Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

NeuroPace Q3 EPS $(0.11) Beats $(0.19) Estimate, Sales $27.354M Beat $24.634M Estimate

Author: Benzinga Newsdesk | November 04, 2025 04:08pm
NeuroPace (NASDAQ:NPCE) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.19) by 42.41 percent. This is a 42.11 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $27.354 million which beat the analyst consensus estimate of $24.634 million by 11.04 percent. This is a 29.89 percent increase over sales of $21.060 million the same period last year.

Posted In: NPCE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist